Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model

Surgical Endoscopy

Volumn 24, Issue 6, 2010, Pages 1427-1433

  Amin, Anwar Tawfik ^a,b   Shiraishi, Norio ^a   Ninomiya, Shigeo ^a   Tajima, Masaaki ^a   Inomata, Masafumi ^a   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

EGFR; Laparoscopy; Microscopic residual cancer; Neoadjuvant chemotherapy; Pneumoperitoneum; Survivin

Indexed keywords

CARBON DIOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARBON DIOXIDE PNEUMOPERITONEUM; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURGICAL STRESS; SURGICAL TECHNIQUE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; GASTROINTESTINAL RADIOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; LAPAROSCOPY; LAPAROTOMY; MECHANICAL STRESS; METABOLISM; PROCEDURES; STOMACH NEOPLASMS; TUMOR CELL CULTURE;

ANIMALS; CARBON DIOXIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LAPAROSCOPY; LAPAROTOMY; MALE; MICE; MICE, INBRED BALB C; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS, EXPERIMENTAL; PNEUMOPERITONEUM, ARTIFICIAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; STRESS, MECHANICAL; TUMOR CELLS, CULTURED;

EID: 77955659569     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0793-8     Document Type: Article

References (35)

1. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH (1998) Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 228:347-354. (Pubitemid 30191697)
2. Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY (2009) Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. Br J Cancer 100:298-304.
3. Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N (2005) Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 65:11018-11025.
4. Jonker DJ, O'Callaghan CJ, Karapetis Cs, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van-Hazel G, Wiezbicki R, Langer C, Moore MJ (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040-2048.
5. Pinto C, Di Fabio F, Siena S, Cascinu S, Rojas Llimpe FL, Ceccarelli C, Mutri V, Gianetta L, Giaquinta S, Funaioli C, Berardi R, Longobardi C, Piana E, Martoni AA (2007) Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FULCETUX study). Ann Oncol 18:510-517.
6. Coffey JC, Wang JH, Smith MJ, Laing A, Bouchier-Hayes D, Cotter TG, Redmond HP (2005) Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. J Biol Chem 280:20968-20977.
7. Lee SW, Gleason N, Blanco I, Asi ZK, Whelan RL (2002) Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy vs insufflation. Surg Endosc 16:36-39.
8. Qadri SS, Wang JH, Coffey JC, Alam M, O'Donnell A, Aherne T, Redmond HP (2005) Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg 79:990-995.
9. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-erbB-2 gene: a 185-kilo Dalton glycoprotein with tyrosine kinase activity. Science 232:1644-1646.
10. Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19:1523-1529.
11. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46-54.
12. Longlley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205:275-292.
13. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117-1123.
14. Wang Q, Greene MI (2005) EGFR enhances survivin expression through the phosphoinositide 3 (IP-3) kinase signaling pathway. Exp Mol Bathol 79:100-107.
15. Qiu L, Wang Q, Di W, Jiang Q, Schefeller E, Derby S, Wanebo H, Yan B, Wan Y (2005) Transient activation of EGFR/AKT pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int J Oncol 27:823-830.
16. Peng XH, Cao ZH, Xia JT, Carlson GW, Lewis MM, Wood WC, Yang L (2005) Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. Cancer Res 65:1909-1917.
17. Ikeguchi M, Liu J, Kaibara N (2002) Expression of survivin mRNA and protein in gastric cancer cell line (MKN45) during cisplatin treatment. Apoptosis 7:23-29.
18. Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Hirata K, Torigoe T, Sato N, Watanabe N (2004) Survivin as a predictor of cis-diammine dichloroplatinum sensitivity in gastric cancer patients. Cancer Sci 95:44-51.
19. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L (2006) Cross-talk between epidermal growth factor receptor and hypoxia inducible factor-1a signal pathways increase resistance to apoptosis by upregulating survivin gene expression. J Biol Chem 281:25903-25914.
20. Matsui Y, Inomata M, Tojigamori M, Sonoda K, Shiraishi N, Kitano S (2005) Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti HER2 antobody in a murine model. Int J Oncol 27:681-685.
21. Suematsu T, Shiromizu A, Yamaguchi K, Shiraishi N, Adachi Y, Kitano S (1999) Convenient murine pneumoperitoneal model for the study of laparoscopic cancer surgery. Surg Laparo Endo Per 9:279-281.
22. Narita T, Taga T, Sugita K, Nakazawa S, Ohta S (2001) The autocrine loop of epidermal growth factor receptor-epidermal growth factor/transforming factor alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC 549. Jpn J Cancer Res 92:269-278.
23. Revillion F, Hornez L, Peyrat JP (1997) Quuatification of c-erbB- 2 gene expression in breast cancer by competitive RT-PCR. Clin Chem 43:2114-2120.
24. Zhang T, Fields JZ, Ehrlich SM (2004) The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells. J Pharmacol Exp Ther 308:434-437.
25. Anwar TA, Shiraishi N, Ninomyia S, Tajima M, Inomata M, Kitano S (2009) Activation of nuclear factor kappa B (NFκB) and induction of migration inhibitory factor (MIF) in tumors by surgical stress of laparotomy vs CO2 pneumoperitoneum: an animal experiment. Surg Endosc. doi:10.1007/s00464-009- 0609-x.
26. Abramovitch R, Marikovsky M, Meir G, Neeman M (1999) Stimulation of tumor growth by wound-derived growth factors. Br J Cancer 79:1392-1398.
27. Rupec RA, Baeuerle PA (1995) The genomic response of tumor cells to hypoxia and reoxygenation: differential activation of transcription factors AP-1 and NFκB. Eur J Biochem 234:632- 640.
28. Lundberg O, Kristoffersson A (2005) Reduction of abdominal wall blood flow by clamping or carbon dioxide insufflation increases tumor growth in the abdominal wall: an experimental study in rats. Surg Endosc 19:720-723.
29. Hsieh HL, Sun CC, Wu CB, Wu CY, Tung WH, Wang HH, Yang CM (2008) Sphnigosine 1-phosphate induces EGFR expression via Akt/NFκB and ERK/Ap-1 pathways in rat vascular smooth muscle cells. J Cell Biochem 103:1732-1746.
30. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A (2000) High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623.
31. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074.
32. Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG (2009) Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era. J Am Coll Surg 208:87-95.
33. Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Menard S (2003) Role of HER2 in wound induced breast carcinoma proliferation. Lancet 362:527-533.
34. Jarnagin WR, Delman K, Kooby D, Mastorides S, Zager J, Brennan MF, Blumgart LH, Federoff H, Fong Y (2000) Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann Surg 231:762-771.
35. Wei JM, Shiraishi N, Goto S, Yasuda K, Inomata M, Kitano S (2008) Laparoscopy-assisted distal gastrectomy with D1 + β compared with D1α lymph node dissection. Surg Endosc 22:955- 960.